Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treating transthyretin (TTR) mediated amyloidosis

Compositions and methods for treating transthyretin (TTR) mediated amyloidosis

US Patent 11806360 · Granted Nov 7, 2023

Estimated economic value: $157,714,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IRAK4 degraders and uses thereof2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression2024
Dosages and methods for delivering lipid formulated nucleic acid molecules2023
GNAQ targeted dsRNA compositions and methods for inhibiting expression2021
Dosages and methods for delivering lipid formulated nucleic acid molecules2019
GNAQ targeted dsRNA compositions and methods for inhibiting expression2018
GNAQ targeted dsRNA compositions and methods for inhibiting expression2017
Lipid formulated compositions and methods for inhibiting expression of Eg5 and V2016
GNAQ targeted dsRNA compositions and methods for inhibiting expression2014
Lipid formulated compositions and methods for inhibiting expression of Eg5 and V2014
GNAQ targeted dsRNA compositions and methods for inhibiting expression2012